跳至主要内容
临床试验/NCT00002304
NCT00002304已完成不适用

A Randomized Comparative Multicenter Trial of Fluconazole and Ketoconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

Pfizer82 个研究点 分布在 2 个国家开始时间: 2001年8月31日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Pfizer
试验地点
82

研究概览

简要总结

To compare the safety, tolerance, and effectiveness of fluconazole and ketoconazole in the treatment of candidal esophagitis in immunocompromised patients.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
13 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Prior Medication:
  • Cyclosporin if levels can be monitored for proper cyclosporin dose adjustment.

排除标准

  • Co-existing Condition:
  • Patients with the following are excluded:
  • Evidence of noncandidal systemic fungal infections.
  • Leukopenia (white blood cell count less than 1000/mm3), or expected to develop leukopenia during the study.
  • Other condition known to be associated with poor ketoconazole absorption, e.g., hypochlorhydria.
  • Leukemia requiring chemotherapy.
  • Any other condition which in the opinion of the investigator would make the patient unsuitable for enrollment.
  • Concurrent Medication:
  • Warfarin.
  • Immunostimulants.
  • Interferon.
  • Oral or topical antifungal agents.
  • Concurrent Treatment:
  • Lymphocyte replacement.
  • Patients with the following are excluded:
  • History of allergy to imidazoles.
  • Abnormalities which may preclude esophagoscopy or endoscopy before or during the study.
  • Inability to tolerate fluconazole or ketoconazole.
  • Inability or unwillingness to give written informed consent.
  • Life expectancy < 2 months.
  • Prior Medication:
  • Rifampin or ansamycin, pending clarification of drug interactions between these drugs and fluconazole.
  • Warfarin.
  • Patients must meet the CDC criteria for the diagnosis of AIDS or be otherwise immunocompromised (e.g., malignancy, renal transplant) and have a diagnosis of oral candidiasis and/or esophageal symptoms of dysphagia and/or odynophagia.
  • Illicit or illegal drug use.

研究者

发起方
Pfizer
申办方类型
Industry

研究点 (82)

Loading locations...

相似试验